InsiderClue
← All stocks

Wave Life Sciences, Inc.

WVE Net buying
CIK 0001631574 #2524 in the set updated 17 Sep 2026
Bought (120 mo)
$166.66M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$58.80M
$6.13M on a plan · $37.39M straight out of an exercise
Sold at will
$15.28M
50 of 144 sales
Net
+$107.86M
+$151.38M against sales at will

By person

19 insiders · 166 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$99.89M (10)
—
+$99.89M
34,549,118
17.53%
$182.76M
+153.8%
GSK plc entity
10% owner
$66.77M (3)
—
+$66.77M
18,245,691
9.26%
$96.52M
+70.8%
BOLNO PAUL
President and CEO
—
$15.80M (30) scheduled
−$15.80M
275,520
0.1398%
$1.46M
+44.4%
Francis Chris
See Remarks
—
$15.78M (34) scheduled
−$15.78M
61,867
0.0314%
$327.28K
—
Tanaka Masaharu
Director
—
$11.31M (3)
−$11.31M
2,774,118
1.41%
$14.68M
−14.1%
Moran Kyle
Chief Financial Officer
—
$4.67M (14) scheduled
−$4.67M
134,385
0.0682%
$710.90K
+1,398%
Verdine Gregory L.
Director
—
$2.08M (9)
−$2.08M
275,217
0.1397%
$1.46M
+223.6%
Tan Aik Na
Director
—
$2.03M (11) scheduled
−$2.03M
24,968
0.0127%
$132.08K
—
Regnante Keith
Chief Financial Officer
—
$1.69M (3) scheduled
−$1.69M
29,186
0.0148%
$154.39K
—
Panzara Michael A.
See Remarks
—
$1.68M (11) scheduled
−$1.68M
109,103
0.0554%
$577.15K
+379.6%
HENRY CHRISTIAN O
Director
—
$1.56M (6) scheduled
−$1.56M
12,700
0.0064%
$67.18K
—
Vargeese Chandra
See Remarks
—
$879.54K (12) scheduled
−$879.54K
408,246
0.2072%
$2.16M
+1,438%
Rawcliffe Adrian
Director
—
$806.60K (3) scheduled
−$806.60K
0
0.0000%
$0.00
—
Wagner Heidi L
Director
—
$231.07K (3) scheduled
−$231.07K
44,930
0.0228%
$237.68K
—
CORRIGAN MARK
Director
—
$217.30K (2) scheduled
−$217.30K
28,815
0.0146%
$152.43K
—
TAKANASHI KEN
Director
—
$65.85K (2) scheduled
−$65.85K
9,626,487
4.89%
$50.92M
+68.7%
Gaiero David G
Interim CFO
—
$4.56K (1)
−$4.56K
6,392
0.0032%
$33.81K
−9.2%
Baldry Mark
Chief Commerical Officer
—
—
—
39,000
0.0198%
$206.31K
—
GUERCIOLINI ROBERTO
See Remarks
—
—
—
4,000
0.0020%
$21.16K
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
RA CAPITAL MANAGEMENT, L.P.
30 Mar 2026
Director
Buy indirect
971,091
$6.50
$6.31M
RA CAPITAL MANAGEMENT, L.P.
27 Mar 2026
Director
Buy indirect
2,495,623
$6.43
$16.05M
RA CAPITAL MANAGEMENT, L.P.
26 Mar 2026
Director
Buy indirect
351,224
$6.38
$2.24M
RA CAPITAL MANAGEMENT, L.P.
26 Mar 2026
Director
Buy indirect
4,954,558
$6.06
$30.02M
GSK plc
11 Dec 2025
10% owner
Buy indirect
1,470,000
$19.00
$27.93M
RA CAPITAL MANAGEMENT, L.P.
13 Nov 2025
Director
Buy indirect
1,000
$6.69
$6.69K
GSK plc
27 Sep 2024
10% owner
Buy indirect
2,791,930
$8.00
$22.34M
RA CAPITAL MANAGEMENT, L.P.
11 Dec 2023
Director
Buy indirect
1,000,000
$5.00
$5.00M
GSK plc
7 Dec 2023
10% owner
Buy indirect
3,300,000
$5.00
$16.50M
RA CAPITAL MANAGEMENT, L.P.
16 Jun 2022
Director
Buy indirect
9,480,052
$2.15
$20.38M
RA CAPITAL MANAGEMENT, L.P.
24 Jan 2019
Director
Buy indirect
263,158
$38.00
$10.00M
RA CAPITAL MANAGEMENT, L.P.
14 Nov 2017
Director
Buy indirect
23,398
$24.00
$561.55K
RA CAPITAL MANAGEMENT, L.P.
13 Nov 2017
Director
Buy indirect
400,000
$23.30
$9.32M
Show all 166 transactions →

What was left out

Form 4 filings counted 226
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,085,925
Sales filed before the plan box existed 46
History held since 14 Nov 2016